|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 229/34 | |
| A61K 31/221 | |||
| A61P 9/00 |
| (11) | Patento numeris | 3317248 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15744416.7 |
| Europos patento paraiškos padavimo data | 2015-07-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/039010 |
| Data | 2015-07-02 |
| (87) | Numeris | WO 2017/003483 |
| Data | 2017-01-05 |
| (72) |
HOOK, David, CH
HU, Bin, US
KLEINBECK, Florian Karl, CH
MEIER, Ulrich, CH
MUELLER, Sibylle, CH
MUTZ, Jean-Paul, CH
SCHLOMACH, Jan, CH
SUTTON, Paul Allen, US
WAYKOLE, Liladhar Murlidhar, US
WIETFELD, Bernhard, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SACUBITRIL CALCIUM SALTS |
| SACUBITRIL CALCIUM SALTS |